Introduction
IL-4 is a 20 kDa glycoprotein originally identified by its ability to support the growth and differentiation of B lymphocytes co-stimulated with submitogenic doses of antiIg (1) . IL-4 is now known to elicit a wide variety of responses by multiple cell types. For example, IL-4 has been shown to promote the differentiation of B lymphocytes and their switch to the production of IgE and IgG1 isotypes (2, 3) , and to be important for the development of cytotoxic T lymphocytes (CTL) (4, 5) . In addition, IL-4 is critical for the differentiation of T h 2 cells (6,7).
IL-4 was initially described as a T cell-derived cytokine (8) and its expression is one of the criteria used to distinguish T h 2 cells from IFN-γ-secreting T h 1 cells (9) . Like many cytokines, however, IL-4 is now recognized to be produced by multiple cell types. For example, IL-4 has been shown to be secreted by mast cells (10) , CTL (11, 12) and γδ T cells (13) . In addition, a population of CD4 ϩ NK1.1 ϩ NK T cells has been shown to promptly produce large amounts of IL-4 following TCR ligation in vivo (14) .
Each of these IL-4-producing cell types can be identified by the expression of specific cell surface markers. 
Methods

Generation of membrane-bound IL-4 mice
The targeting construct used to generate a knock-in of the IL-4 locus contained exons 3 and 4 of the IL-4 gene, and was bounded by the EcoRI site located 1 kb upstream of exon 3 and the XbaI site located 3 kb downstream of exon 4 (17) . Exon 4 of the murine IL-4 gene was modified by recombinant PCR to contain a transmembrane anchor. Briefly, the fourth exon of the MHC class II A β b gene (18) , encoding the connecting peptide, the transmembrane region and the first six amino acids of the cytoplasmic tail, was inserted between the last codon and the translational stop site of the IL-4 gene. A cassette containing the neomycin resistance gene was placed 150 nucleotides downstream of the polyadenylation signal of the IL-4 gene. The targeting construct was transfected into day 3 embryonic stem cells as described (19) . Homologous recombinants were identified by Southern analysis of EcoRI-digested DNA using the 3Ј probe shown in Fig. 1 ; this probe detects a 7 kb fragment of the wildtype allele and a 4.5 kb fragment of the mIL-4 allele. One homologous recombinant was used to generate chimeras that passed the mIL-4 allele through the germline. Mice were genotyped using the primers shown in Fig. 1 and having the sequence: IL-4 upstream, 5Ј-GAG ACC CAA ATC TGT CTC AC-3Ј; IL-4 downstream, 5Ј-GTT AAA GCA TGG TGG CTC AG-3Ј. Unless otherwise noted, all experiments were done on 3-to 4-month-old homozygous mIL-4 mice which had been backcrossed six generations onto the BALB/c genetic background.
In vitro differentiation of T h 2 cells
Spleen cells from wild-type and mIL-4 mice were stimulated in vitro with 1 µg/ml plate-bound anti-CD3 (2C11) and 20 µg/ml anti-IL-12 (5C3). Twenty-four hours later, 50 U/ml IL-2 and 500 U/ml IL-4 were added. Seven days post-stimulation, cells were harvested, washed and re-stimulated with plate-bound anti-CD3 for 24 h. Cells were then stained with FITC-conjugated anti-IL-4 (11B11) (PharMingen, San Diego, CA) and analyzed by flow cytometry.
Preparation and stimulation of peritoneal mast cells
Mouse peritoneal mast cells were prepared as described (20) . Briefly, the peritoneal cavity was lavaged with 10 ml modified Tyrode's buffer (2.7 mM KCl, 12 mM NaHCO 2 , 0.4 mM NaH 2 PO 4 , 0.14 M NaCl, 0.1% glucose, 0.1% gelatin). The recovered peritoneal cells were washed once, resuspended in modified Tyrode's buffer (1 ml/pooled cells from 10 mice), layered onto a solution of 22.5% metrizamide and centrifuged for 12 min at 1500 r.p.m. The cell pellet was harvested, washed twice and used as a source of enriched mast cells. Enriched mast cells were then stimulated with 1 µM ionomycin for 6-8 h, stained with FITC-conjugated anti-IL-4 and analyzed by flow cytometry. 
In vivo immunization
Anti-CD3 (100 µg per animal in 100 µl of PBS) or PBS was administered i.v. by injection into the tail vein. Spleen cells were harvested 5-6 h post-injection, stained with FITCconjugated anti-IL-4 and analyzed by flow cytometry. Immunization with anti-IgD was performed as described (19) . Spleen cells were harvested 10 days post-injection, stimulated overnight in vitro with plate-bound anti-CD3, stained with FITCconjugated anti-IL-4 and analyzed by flow cytometry.
Results and discussion
Generation of mIL-4 mice
The targeting construct used to generate mIL-4 mice is shown in Fig. 1 . Briefly, the fourth exon of the IL-4 gene was modified by recombinant PCR to contain the connecting peptide, the transmembrane region and the first six amino acids of the cytoplasmic tail of the MHC class II A β b gene. A cassette containing the neomycin-resistance gene was placed 150 nucleotides downstream of the polyadenylation signal of the IL-4 gene. The targeting construct was transfected into day 3 embryonic stem cells and homologous recombinants were identified by Southern analysis as described in Methods. One clone was used to generate chimeras that passed the mIL-4 allele through the germline. Heterozygous offspring were backcrossed six generations onto the BALB/c genetic background and then intercrossed to generate homozygous mIL-4 mice (Fig. 1) .
Detection of IL-4-producing T h 2 cells
To determine if mIL-4 can be detected on the cell surface of differentiated CD4 ϩ T h 2 cells, we used an in vitro differentiation protocol to enrich for this population. Spleen cells from wildtype and mIL-4 mice were stimulated with plate-bound anti-CD3 in the presence of IL-4 and anti-IL-12 for 7 days. Cells were then re-stimulated with plate-bound anti-CD3 for 24 h and analyzed by flow cytometry for the expression of mIL-4 using 11B11 mAb. mIL-4 ϩ cells could not be detected from cultures of differentiated wild-type cells (Fig. 2) nor from cultures of unstimulated spleen cells irrespective of their (21) . To determine if IL-4-secreting mast cells can be detected in mIL-4 mice, peritoneal mast cells from wild-type and mIL-4 mice were generated as described in Methods. Microscopic examination revealed that Ͼ50% of the peritoneal cells prepared by this method were large granule-containing cells having a morphology consistent with being mast cells. When analyzed by flow cytometry using 11B11 mAb,~1-2% of this mast cell enriched population from mIL-4 mice stained positive at baseline (Fig. 3) . Strikingly, Ͼ7% of the cells became positive for mIL-4 expression after only 6 h of stimulation with ionomycin. Flow cytometric analysis of ionomycin-activated cells from mIL-4 mice with an IL-2-specific antibody, or of ionomycin-activated cells from wildtype mice with 11B11 mAb, failed to reveal specific staining.
Thus, these data demonstrate that IL-4-producing mast cells from mIL-4 mice can be detected by flow cytometry using 11B11 mAb. of their TCR by anti-CD3 in vivo (14) . These cells are most easily identified by their cell surface expression of both CD4 and NK1.1. Since the mIL-4 mice were on a BALB/c genetic background and this strain does not express the NK1.1 marker, we mated mIL-4 mice to C57BL/6 mice to generate (BALB/cϫC57BL/6)F 1 animals which expressed the NK1.1 marker and were heterozygous for the mIL-4 allele. These F 1 mIL-4 mice and wild-type C57BL/6 controls were injected with anti-CD3 i.v. When analyzed by flow cytometry 6 h postinjection with anti-CD3,~1% of total spleen cells obtained from F 1 mIL-4 mice stained positive with 11B11 mAb (Fig. 4A) . Consistent with previous reports documenting the phenotype of splenic IL-4-secreting NK T cells (22) , these mIL-4 ϩ cells were CD44 high , Mel14 low (Fig. 4B) . Interestingly, none of the cells expressing high levels of NK1.1 stained positive for mIL-4, but rather mIL-4 ϩ cells were equally divided into NK1.1 low and NK1.1 -subpopulations. This observation may be related to the recent demonstration that in vitro, expression of the NK1.1 marker is down-regulated on NK T cells following activation (23) . Alternatively, at least some of the mIL-4 ϩ NK1.1 -cells may represent memory T h 2 cells. Nevertheless, these results demonstrate that mIL-4 expression can be used as a marker for IL-4-producing NK T cells.
Detection of IL-4-producing NK T cells NK T cells represent a small percentage of splenic lymphoid cells (~1%) but secrete large amounts of IL-4 upon ligation
In addition to their role in anti-CD3-induced IL-4 production, NK T cells are also thought to be the predominant producers of IL-4 following immunization with the polyclonal stimulus anti-IgD (24) . CD1-deficient mice lack the major population of NK T cells and do not acutely produce IL-4 following in vivo stimulation with anti-CD3 (25) (26) (27) . Nevertheless, these mice generate normal IgE antibody responses following administration of anti-IgD. These observations suggest that separate subpopulations of IL-4-secreting NK T cells, as defined by their ability to respond to different activating stimuli such as anti-CD3 or anti-IgD, may exist. To test this hypothesis, wildtype and mIL-4 mice were immunized with anti-IgD. Spleen cells were harvested 10 days after immunization and restimulated with plate-bound anti-CD3 in vitro for 24 h. Similar to that seen following injection of anti-CD3 in vivo, flow cytometric analysis of spleen cells from anti-IgD immunized mIL-4 mice demonstrated that~1% of the cells were mIL-4 ϩ and, of these, almost all were CD3 ϩ CD4 ϩ CD44 high Mel14 low (data not shown). Since, mIL-4 mice on the BALB/c genetic background do not express the NK1.1 marker, we examined the expression of the pan-NK cell marker DX5 on mIL-4 ϩ cells. Approximately 30% of the mIL-4 ϩ spleen cells derived from anti-IgD injected mIL-4 mice were positive for the DX5 marker (Fig. 5) . In contrast, almost none of the mIL-4 ϩ spleen cells derived from anti-CD3-injected mIL-4 mice expressed the DX5 marker ( Fig. 4B and 5) . Thus, these data suggest that there are at least two populations of IL-4-producing NK T cells; those that are DX5 -and stimulated in response to anti-CD3, and those that are DX5 ϩ and activated in response to anti-IgD. While it is possible that the IL-4-producing DX5 -NK T cells seen in anti-IgD-injected mice are the same population of IL-4-producing NK1.1 low/-cells seen in anti-CD3-injected mice, the (BALB/cϫC57BL/6) F 1 mIL-4 mice did not respond well to anti-IgD injection, thus preventing a direct test of this hypothesis. Nevertheless, these results demonstrate that IL-4-producing NK T cells are a heterogeneous population, and may explain the differences seen in the ability of CD1-deficient mice to mount acute versus chronic IL-4 responses to immunization with anti-CD3 and anti-IgD respectively.
In this report, we have shown that multiple IL-4-secreting cell types from mIL-4 mice, including T h 2 cells, mast cells and NK T cells, could be detected by flow cytometry using an IL-4-specific mAb. Since the expression of the mIL-4 allele is driven by the endogenous IL-4 promoter in the context of its normal location in the genome, the transcription of this gene is regulated in a manner that is both quantitatively and qualitatively identical to the wild-type allele. Thus, knock-in of the IL-4 locus represents the most physiological approach to mark, track and/or sort IL-4-producing cells given the lack of a natural marker. mIL-4 mice will allow the easy identification and purification of IL-4-producing cells for the study of their roles in animal models of disease.
